Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Mild essential fatty acid deficiency can cause health issues and is worsened by low-fat diets.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Melatonin may help treat PCOS symptoms in rats.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Balding people may have higher heart disease risk.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Skin tags in obese individuals may indicate higher cardiovascular risk.